Brief

US Opens Duty Probe Into Chinese Medicinal Chemical

By Jack McLoone ( May 15, 2026, 6:32 PM EDT) -- The U.S. Department of Commerce said Friday it will examine a pharmaceutical compound imported from China to determine whether it has been subsidized and sold at less than fair value, potentially setting up countervailing and antidumping duties....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login